Add to ORKGThe use of liposomal doxorubicin in place of conventional form can significantly reduce the risk of clinically important cardiovascular complications of chemotherapy. The use of liposomal doxorubicin-containing regimen seems to be the most justified in treatment of breast cancer patients with coexisting cardiovascular diseases. The document defines the possible clinical scenarios for the use of chemotherapy with liposomal doxorubicin and presents the optimal cardiac monitoring of this therapy
Purpose To investigate the cardiac safety of adjuvant Non-Pegylated Liposomal Doxorubicin (NPL-DOX) ...
Simple Summary Anthracyclines are among the most active chemotherapies in breast cancer (BC). Howeve...
Simple Summary Anthracyclines are among the most active chemotherapies in breast cancer (BC). Howeve...
The use of liposomal doxorubicin in place of conventional form can significantly reduce the risk of ...
Abstract Anthracyclines remain amongst the most active therapeutic agents for breast cancer treatmen...
Metastatic breast cancer (MBC) remains a major cause of morbidity and mortality in women worldwide. ...
Anthracycline-containing regimens have demonstrated significant disease-free and overall survival be...
Anthracyclines are among the most effective drugs for patients with breast cancer. Their use, howeve...
Iain RJ Macpherson, TR Jeffry EvansBeatson West of Scotland Cancer Centre, Glasgow, United KingdomAb...
Various trials have compared the efficacy and toxicity of liposomal doxorubicin-based chemotherapy w...
Yesenia L Franco,* Tanaya R Vaidya,* Sihem Ait-Oudhia Center for Pharmacometrics and Systems Pharmac...
The anthracycline doxorubicin is among the most active dugs in breast cancer and included in chemoth...
12PURPOSE: Anthracyclines and fluoropyrimidines are very active in breast cancer, while liposoma...
Background Various trials have compared the efficacy and toxicity of liposomal doxorubicin-based che...
Anthracyclines are among the most active antineoplastic drugs developed to date, used both in the tr...
Purpose To investigate the cardiac safety of adjuvant Non-Pegylated Liposomal Doxorubicin (NPL-DOX) ...
Simple Summary Anthracyclines are among the most active chemotherapies in breast cancer (BC). Howeve...
Simple Summary Anthracyclines are among the most active chemotherapies in breast cancer (BC). Howeve...
The use of liposomal doxorubicin in place of conventional form can significantly reduce the risk of ...
Abstract Anthracyclines remain amongst the most active therapeutic agents for breast cancer treatmen...
Metastatic breast cancer (MBC) remains a major cause of morbidity and mortality in women worldwide. ...
Anthracycline-containing regimens have demonstrated significant disease-free and overall survival be...
Anthracyclines are among the most effective drugs for patients with breast cancer. Their use, howeve...
Iain RJ Macpherson, TR Jeffry EvansBeatson West of Scotland Cancer Centre, Glasgow, United KingdomAb...
Various trials have compared the efficacy and toxicity of liposomal doxorubicin-based chemotherapy w...
Yesenia L Franco,* Tanaya R Vaidya,* Sihem Ait-Oudhia Center for Pharmacometrics and Systems Pharmac...
The anthracycline doxorubicin is among the most active dugs in breast cancer and included in chemoth...
12PURPOSE: Anthracyclines and fluoropyrimidines are very active in breast cancer, while liposoma...
Background Various trials have compared the efficacy and toxicity of liposomal doxorubicin-based che...
Anthracyclines are among the most active antineoplastic drugs developed to date, used both in the tr...
Purpose To investigate the cardiac safety of adjuvant Non-Pegylated Liposomal Doxorubicin (NPL-DOX) ...
Simple Summary Anthracyclines are among the most active chemotherapies in breast cancer (BC). Howeve...
Simple Summary Anthracyclines are among the most active chemotherapies in breast cancer (BC). Howeve...